rosuvastatin gel (1.2% local gel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rosuvastatin gel (1.2% local gel), covering 2017-02-03 to 2017-02-03. Get the full timeline:
Most recent: Clinical Trial Update: 1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis [Phase 2, Phase 3]